Navigation Links
LITHOSTAR Multiline

ProductsLITHOSTAR Multiline
Company Siemens Medical Solutions Urology
Item LITHOSTAR Multiline
Features 
  • Effective therapy with Siemens patented electromagnetic Shock Wave System M
  • Precise stone imaging in-line/off-line fluoroscopy and optional ultrasound
  • Streamlined, user-friendly system operation
  • State-of-the-art lithotripter and a fully-functional urology system
Description The Siemens LITHOSTAR Multiline offers an ideal combination of performance and flexibility enabling fast, easy and effective treatment of urinary tract stones, as well as a wide range of urological applications.

The state-of-the-art digital system produces crystal-clear images enabling rapid, precise stone localization. Developed for highly effective therapy, the LITHOSTAR Multilines electromagnetic shock waves were designed to treat stones not healthy tissue through the optimization of the focal zone to typical stone size. The result is precise targeting, optimal penetration depth and enhanced outcomes. In addition, a large coupling surface optimizes shock wave distribution, reducing the perception of pain on the skin and in the tissues. In most cases, patients can be treated without anesthesia, reducing risk, time and expense.

Info Siemens Medical Solutions Urology
Customer Service: (888) 826-9702
Web site: http://www.usa.siemens.com/medical

Related medicine products :

1. Medstone Pro-2000CV Table
2. Medstone Pro-2000BT Carbon Fiber C-arm Table
Ideal for abdominal procedures...
For lipoplasty of trochanteric region, abdomen, thighs, hips/flanks, buttocks, knees, calves and ankles...
CDIs original garments with our exclusive Wonderfabric™....
Short Girdle, Mid-thigh, Front Closure...
Medicine Products:
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
(Date:8/31/2015)... Illinois (PRWEB) , ... August 31, 2015 , ... ... their AdvantaClean franchise business with a ribbon-cutting ceremony on Aug. 26, generously hosted ... calls and booking inspection appointments via AdvantaClean’s National Call Center and website since ...
(Date:8/31/2015)... ... 31, 2015 , ... Physicians’ Education Resource®, LLC (PER®) ... Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for its ... City. The annual legacy meeting uses a variety of formats to educate all ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... peers may be at a greater risk for injury, potentially because they are ... University of Pittsburgh Graduate School of Public Health analysis discovered. , The ...
(Date:8/31/2015)... ... August 31, 2015 , ... On Saturday, May 30th, ... at the Adams County Fairgrounds in Mendon, IL. The purpose behind this concert was ... Mendon and neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music with a Mission” ...
Breaking Medicine News(10 mins):Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3
... really mysterious, however these have inspired a computational technique ... affected by the// personality disorder schizophrenia. Researchers feel the ... that can help diagnose the condition. ,Exactly ... schizophrenia is yet to be pinned down. Raymond Deicken ...
... abuse can be moderately improved by various psychotherapy treatments ... the best clinicians// can hope for at this time, ... behavioral therapy (CBT) is most effective, but other counseling ... social problems associated with their marijuana use. ...
... and Clinical Excellence (NICE) has brought out guidance to ... to help adult patients suffering acute plaque psoriasis. Despite ... benefits for many patients in Europe due to the ... for many thousands of patients across United Kingdom who ...
... research done by Eyal Raz, Sandip Datta and Joshua ... Medicine it was found that gamma radiation// killed bacteria ... against the bacterial disease. ,The U.S. National ... researches in their finding and said that these bacterial ...
... who completed a management course here and agreed to be part ... effects of the trial and is looking// forward to returning to ... trial for US testing firm Parexel in March, but is now ... He is reported to be taking antidepressants and medication to stop ...
... which a specific cell protein trigger the spread of cancer ... by researchers in the Cell Signalling Unit, University of Edinburgh ... which limit the protein's ability to turn a normal cell ... the activity of a key cancer preventing protein called p53. ...
Cached Medicine News:Health News:Diagnosing Schizophrenia 2Health News:Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat 2Health News:Marijuana Abuse Responds to Psychotherapy, Overall Is Hard to Treat 3Health News:NICE supports application of advanced biological therapies as treatment option for acute psoriasis 2Health News:NICE supports application of advanced biological therapies as treatment option for acute psoriasis 3Health News:NICE supports application of advanced biological therapies as treatment option for acute psoriasis 4
(Date:8/31/2015)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ), the nation,s ... , Chairman & CEO, and Sean Whelan , CFO, ... Mr. Hagerman and Mr. Whelan are scheduled to participate in ... on Wednesday, September 9, 2015 at 1:45 PM ... scheduled to participate in the Robert W. Baird 2015 Healthcare ...
(Date:8/31/2015)... 31, 2015  Qualcomm Incorporated (NASDAQ: QCOM ... Life, Inc., is collaborating with Davita Healthcare ... solutions powered by Qualcomm Life,s 2net™ Device Connectivity ... continuous care, informed interventions and better management of ... Life,s annual Connect 2015 ecosystem conference ...
(Date:8/31/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced that the third ... -based Rush University Medical Center in a ... doses of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... spinal cord injury (SCI). This represents the final ...
Breaking Medicine Technology:Diplomat to Participate in Upcoming Investor Conferences 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6